Pfizer Inc (NYSE:PFE)
| 41.68 Delayed Data As of Jul 23 |  +0.21 / +0.51%Today’s Change | 32.80 Today|||52-Week Range 43.08 | +13.23% Year-to-Date |
PFE Regular Dividend: PFE will begin trading ex-dividend on 07/29/21 with a $0.39 dividend payable to shareholders of record as of 07/30/21.
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 41.47 |
| Today’s open | 41.04 |
| Day’s range | 41.42 - 41.83 |
| Volume | 21,609,212 |
| Average volume (3 months) | 26,009,322 |
| Market cap | $225.9B |
Data as of 5:00pm ET, 07/23/2021
Growth & Valuation
| Earnings growth (last year) | -40.76% |
| Earnings growth (this year) | +66.04% |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | -19.02% |
| P/E ratio | 25.1 |
| Price/Sales | 4.95 |
| Price/Book | 3.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +5.63 | +2.36% |
| ABBVAbbVie | +0.63 | +0.54% |
| NVSNovartis | +0.52 | +0.57% |
| MRKMerck | +1.01 | +1.32% |
Data as of 4:28pm ET, 07/23/2021
Financials
| Next reporting date | July 28, 2021 |
| EPS forecast (this quarter) | $0.97 |
| Annual revenue (last year) | $41.9B |
| Annual profit (last year) | $9.6B |
| Net profit margin | 16.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
